Share This Page
Drug Price Trends for RISEDRONATE SODIUM
✉ Email this page to a colleague
Average Pharmacy Cost for RISEDRONATE SODIUM
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| RISEDRONATE SODIUM 150 MG TAB | 47335-0928-60 | 15.68047 | EACH | 2024-12-18 |
| RISEDRONATE SODIUM 150 MG TAB | 47335-0928-67 | 15.68047 | EACH | 2024-12-18 |
| RISEDRONATE SODIUM 150 MG TAB | 00093-7771-79 | 15.68047 | EACH | 2024-12-18 |
| RISEDRONATE SODIUM 150 MG TAB | 59762-0406-01 | 15.68047 | EACH | 2024-12-18 |
| RISEDRONATE SODIUM 150 MG TAB | 00093-7771-13 | 15.68047 | EACH | 2024-12-18 |
| RISEDRONATE SODIUM 5 MG TABLET | 33342-0107-07 | 1.30974 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Risedronate Sodium
Introduction to Risedronate Sodium
Risedronate sodium is a bisphosphonate drug commonly used to treat conditions such as osteoporosis, Paget's disease, and to prevent osteoporosis. It is available under brand names like Atelvia and Actonel, and its efficacy in reducing bone loss and preserving bone health has made it a significant player in the osteoporosis drugs market[2][3][4].
Market Size and Growth Projections
The market for risedronate sodium, as part of the broader osteoporosis drugs market, is experiencing substantial growth. The osteoporosis drugs market was valued at USD 15.8 billion in 2023 and is expected to grow at a CAGR of 4.6% from 2024 to 2032, reaching USD 23.2 billion by 2032[3].
Specifically, the risedronate sodium API market is forecasted to continue its rapid and substantial growth from 2023 to 2031. This growth is driven by factors such as increasing prevalence of osteoporosis, rising geriatric population, and advancements in medical technology[1].
Market Segmentation
The risedronate sodium market can be segmented based on several criteria:
Type
- The market is categorized into purity levels such as ≥99% and ≥99.5% purity, which affects the pricing and application of the drug[1].
Application
- Risedronate sodium is primarily used in the form of tablets and capsules. The oral tablet segment dominates the market due to its ease of administration and patient compliance[1][4].
Geographical Regions
- The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. Each region has its own growth dynamics influenced by local healthcare policies, awareness, and economic conditions[1].
Price Analysis
The prices of risedronate sodium vary based on the dosage and form of the medication.
Oral Tablets
- A supply of 4 tablets of 35 mg risedronate sodium oral tablets can cost around $48, depending on the pharmacy. For a 30-tablet supply of 5 mg tablets, the cost can range from $117.21 to $665.95 for 30 mg tablets[2].
Oral Delayed Release Tablets
- The cost for a 4-tablet supply of 35 mg oral delayed release tablets can start from $155.95[2].
Drivers and Restraints
Drivers
- The growing aging population and increasing awareness about bone health are significant drivers. Innovations in oral medication delivery systems, such as extended-release formulations, also enhance patient compliance and treatment outcomes[4].
- Advances in medical technology, including bone density scanning techniques, further support market growth[3].
Restraints
- High costs associated with drug development and regulatory hurdles in clinical trials are major restraints. Potential side effects and the development of alternative treatments like biologics also pose challenges[4].
Competitive Landscape
The risedronate sodium market is competitive, with major pharmaceutical companies investing heavily in research and development. Key players are focused on enhancing drug efficacy, reducing side effects, and improving patient compliance through innovative formulations and delivery methods[1][4].
Porter’s Five Forces Analysis
This analysis helps in understanding the competitive position of businesses in the risedronate sodium market. It identifies the strength of the current competitive position and potential repositioning opportunities. Key factors include:
- Threat of New Entrants: High barriers to entry due to regulatory and development costs.
- Bargaining Power of Suppliers: Moderate due to the availability of multiple suppliers.
- Bargaining Power of Buyers: High due to the presence of generic alternatives and patient awareness.
- Threat of Substitute Products: Moderate due to the emergence of alternative bisphosphonates and biologics.
- Competitive Rivalry Among Existing Competitors: High due to the presence of multiple established players[4].
Market Opportunities
- Emerging Markets: Expanding osteoporosis treatments in emerging markets offers significant growth opportunities.
- Enhanced Delivery Methods: Developing extended-release formulations and leveraging digital health tools to enhance patient education and monitor medication adherence.
- Personalized Medicine: Research into personalized medicine approaches focusing on genetic and lifestyle factors influencing bone health[4].
Challenges
- Regulatory Reforms: Addressing regulatory reforms affecting distribution and approval processes.
- Market Competition: Evaluating the impact of new pharmaceutical collaborations and alternative bisphosphonate options on market dynamics.
- Side Effects and Alternative Treatments: Managing potential side effects and the development of alternative treatments[4].
Key Takeaways
- The risedronate sodium market is poised for significant growth driven by increasing prevalence of osteoporosis and advancements in medical technology.
- The market is segmented based on type, application, and geographical regions.
- Prices vary based on dosage and form, with oral tablets being the dominant form.
- Drivers include a growing aging population and innovations in delivery systems, while restraints include high development costs and regulatory hurdles.
- The competitive landscape is marked by significant investment in R&D by major pharmaceutical companies.
FAQs
1. What is risedronate sodium used for? Risedronate sodium is used to treat conditions such as osteoporosis, Paget's disease, and to prevent osteoporosis.
2. What are the brand names for risedronate sodium? Brand names for risedronate sodium include Atelvia and Actonel.
3. How is the risedronate sodium market segmented? The market is segmented based on type (purity levels), application (tablets, capsules), and geographical regions.
4. What are the key drivers of the risedronate sodium market? Key drivers include the growing aging population, increasing awareness about bone health, and innovations in oral medication delivery systems.
5. What are the major restraints in the risedronate sodium market? Major restraints include high costs associated with drug development, regulatory hurdles, potential side effects, and the development of alternative treatments.
Cited Sources
- Market Research Intellect: Risedronate Sodium API Market Size, Scope And Forecast Report.
- Drugs.com: Risedronate Prices, Coupons, Copay Cards & Patient Assistance.
- GMI Insights: Osteoporosis Drugs Market Size – Trends Report, 2032.
- 360 Research Reports: Risedronate Sodium Tablets Market Size & Share 2025-2030.
More… ↓
